What Researchers Did
Researchers reviewed their experience treating eight patients with radiation-induced hemorrhagic cystitis using hyperbaric oxygen therapy between 2001 and 2007.
What They Found
The study found that hematuria completely resolved in six of the eight patients (75% response rate) who received hyperbaric oxygen therapy for radiation-induced hemorrhagic cystitis. One patient experienced a recurrence but was successfully re-treated, and no side-effects of HBO were observed during the treatment period.
What This Means for Canadian Patients
For Canadian patients suffering from radiation-induced hemorrhagic cystitis, this study suggests that hyperbaric oxygen therapy could be an effective treatment option to resolve severe bleeding. This non-invasive approach may offer relief and improve quality of life for those experiencing this challenging complication of radiation therapy.
Canadian Relevance
Radiation-induced hemorrhagic cystitis is a recognised complication of radiation therapy, for which hyperbaric oxygen therapy is a Health Canada-recognised indication for radiation tissue damage.
Study Limitations
A significant limitation of this study is its small sample size of only eight patients, which limits the generalizability of the findings.